Current State of Endoscopic Bariatric Therapies

Authors

Lee Ying, Department of Surgery, Yale School of Medicine, PO Box 208062, New Haven, CT 06520, USA.Follow
Samuel Butensky, Department of Surgery, Yale School of Medicine, PO Box 208062, New Haven, CT 06520, USA.Follow
Ysabel Ilang-Ying, Department of Gastroenterology, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.Follow
Saber Ghiassi, Department of Surgery, Yale School of Medicine, PO Box 208062, New Haven, CT 06520, USA. Electronic address: Saber.ghiassi@yale.edu.Follow

Document Type

Article

Publication Title

The Surgical clinics of North America

Abstract

The obesity epidemic poses a significant global health challenge. Despite proven efficacy, accessibility to bariatric surgery is limited. Endoscopic bariatric therapies offer less invasive alternatives. Reversible space-occupying devices like intragastric balloons are suitable for both primary obesity treatment and bridging to surgery. Restrictive therapies that reduce gastric volume like the primary obesity surgery endoluminal and endoscopic sleeve gastroplasty have shown promising short-term results. Diverting devices such as intestinal liners/barriers or magnet-assisted anastomoses aim to replicate surgical effects with lower risks, though efficacy varies. Finally, endoscopic revisional procedures like transoral outlet reduction address weight regain post-bariatric surgery.

First Page

159

Last Page

171

DOI

10.1016/j.suc.2024.06.012

Publication Date

2-1-2025

Recommended Citation

Ying, Lee; Butensky, Samuel; Ilang-Ying, Ysabel; and Ghiassi, Saber, "Current State of Endoscopic Bariatric Therapies" (2025). Surgery. 166.
https://scholar.bridgeporthospital.org/surgery/166

Identifier

39523071 (pubmed); 10.1016/j.suc.2024.06.012 (doi); S0039-6109(24)00098-7 (pii)